Keith Norris to Phosphorus
This is a "connection" page, showing publications Keith Norris has written about Phosphorus.
Connection Strength
0.630
-
Norris KC. The impact of calcium in phosphorus management. Excess calcium load in chronic renal failure adds risk for patients. Nephrol News Issues. 2001 Nov; 15(12):17, 20, 23-4 passim.
Score: 0.199
-
Mehrotra R, Peralta CA, Chen SC, Li S, Sachs M, Shah A, Norris K, Saab G, Whaley-Connell A, Kestenbaum B, McCullough PA. No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. Kidney Int. 2013 Nov; 84(5):989-97.
Score: 0.110
-
Kalantar-Zadeh K, Miller JE, Kovesdy CP, Mehrotra R, Lukowsky LR, Streja E, Ricks J, Jing J, Nissenson AR, Greenland S, Norris KC. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res. 2010 Dec; 25(12):2724-34.
Score: 0.091
-
Vassalotti JA, Uribarri J, Chen SC, Li S, Wang C, Collins AJ, Calvo MS, Whaley-Connell AT, McCullough PA, Norris KC. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008 Apr; 51(4 Suppl 2):S56-68.
Score: 0.077
-
Norris KC, Greene T, Kopple J, Lea J, Lewis J, Lipkowitz M, Miller P, Richardson A, Rostand S, Wang X, Appel LJ. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol. 2006 Oct; 17(10):2928-36.
Score: 0.069
-
Brown-Tortorici AR, Narasaki Y, You AS, Norris KC, Streja E, Peralta RA, Guerrero Y, Daza A, Arora R, Lo R, Nakata T, Nguyen DV, Kalantar-Zadeh K, Rhee CM. The Interplay between Dietary Phosphorous, Protein Intake, and Mortality in a Prospective Hemodialysis Cohort. Nutrients. 2022 Jul 26; 14(15).
Score: 0.052
-
Omije D, Norris K, Wang J, Pan D, Kermah D, Gupta A. Race is a major determinant of secondary hyperparathyroidism in uremic patients: comparative study of Blacks and Hispanics. Clin Nephrol. 2008 Oct; 70(4):312-8.
Score: 0.020
-
Fraz?o JM, Elangovan L, Maung HM, Chesney RW, Acchiardo SR, Bower JD, Kelley BJ, Rodriguez HJ, Norris KC, Robertson JA, Levine BS, Goodman WG, Gentile D, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. Am J Kidney Dis. 2000 Sep; 36(3):550-61.
Score: 0.011